|
A.A. Kamalov, D.A. Ohobotov, A.V. Kadrev, R.M. Gorbunov, A.P. Mikhalchenko, A.A. Strigunov, O.Yu. Nesterova, D.A. Tsigura
Sildenafil citrate spray and tablets: first results from a single center comparative study
|
№3 / 2022
|
|
B.A. Neymark, A.I. Neymark, Ya.V. Yakovets, N.A. Nozdrachev, Kh.S. Ibishev, I.V. Kuzmin
Management of lower urinary tract symptoms in patients with benign prostatic hyperplasia during COVID-19. results of an all-russian observational study “ATLANT”
|
№1 / 2022
|
|
M.E. Chaliy, D.A. Ohobotov, N.I. Sorokin, A.V. Kadrev,
L.I. Dyachuk, A.A. Strigunov, O.Yu. Nesterova,
A.V. Mikhalchenko, A.A. Kamalov
Normative parameters for monitoring of nocturnal penile tumescences: a systematic review and algorithm development
|
№6 / 2021
|
|
M.N. Korshunov, E.S. Korshunova, Yu.V. Kastrikin,
E.A. Efremov, S.P. Darenkov
The role of male factor in pregnancy loss
|
№4 / 2021
|
|
Z.R. Shodmonova, R.R. Gafarov, S.A. Allazov, Sh.I. Giyasov
Phosphodesterase type 5 inhibitors – clinical efficiency and role in therapy for erectile dysfunction
|
№2 / 2021
|
|
E.A. Sokolov, E.I. Veliev, R.A. Veliev
Feasibility and risks of nerve-sparing technique of radical prostatectomy in elderly patients
|
№2 / 2021
|
|
A.I. Neymark, B.A. Neymark, A.V. Davydov, N.A. Nozdrachev, I.V. Kablova, Ya.V. Yakovets, V.P. Levin
Possibilities of using sildenafil in patients with cardiovascular comorbidities who underwent transurethral resection of the prostate
|
№6 / 2020
|
|
M.I. Kogan, Ig.V. Popov, Il. V. Popov, S.S. Todorov
Penile cavernous fibrosis: etiology, morphogenesis, erectile dysfunction
|
№4 / 2020
|
|
V.V. Borisov
Combination of α1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
|
№3 / 2020
|
|
N.D. Akhvlediani, A.S. Chernushenko, D.Yu. Pushkar, A.N. Bernikov, I.A. Reva
Surgical approaches for implanting of three-piece penile prosthetics
|
№6 / 2019
|
|
A.A. Kaputovskij
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction
|
№6 / 2019
|
|
P.V. Glybochko, Z.K. Gadzhievа, Yu.G. Alyaev, M.A. Gazimiev
Multidisciplinary approach in urology. Clinical aspects
|
№4 (приложение) / 2019
|
Русский
